Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2022

The forecast has been updated: September 23, 2022 9:28


Biohaven Pharmaceutical Holding stock price online today

Analyst Target Price

153.5

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Biohaven Pharmaceutical Holding stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Biohaven Pharmaceutical Holding stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $153.5 target price for Biohaven Pharmaceutical Holding stock stock.

Today 200 Day Moving Average is the support level (128.58 $).

50 Day Moving Average is the support level (145.66 $).




BHVN Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Oct 149.65 139.12 159.04 12.52 %
Nov 162.99 157.25 171.77 8.45 %
Dec 160.48 150.06 171.60 12.55 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Biohaven Pharmaceutical Holding stock.


Biohaven Pharmaceutical Holding overview

Biohaven Pharmaceutical Holding Address

215 CHURCH STREET, NEW HAVEN, CT, US

Market Capitalization

10 581 945 000 $

EBITDA

-616 985 024

PE Ratio

None

PEG Ratio

0

Dividend Per Share

0

Dividend Yield

0

EPS

-11.85

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

1.314

Trailing PE

-

Forward PE

-

EV To Revenue

12.53

EV To EBITDA

-14.88

52 Week High

151.51

52 Week Low

79.01

50 Day Moving Average

145.66

200 Day Moving Average

128.58

Shares Outstanding

71495000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Biohaven Pharmaceutical Holding stock forecast for this year


Biohaven Pharmaceutical Holding stock forecast for Oct 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 149.65. Positive monthly dynamics of the instrument is expected with 12.525% volatility is expected.

Pessimistic forecast: 139.12

Optimistic: 159.04


Biohaven Pharmaceutical Holding stock forecast for Nov 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 162.99. Positive monthly dynamics of the instrument is expected with 8.454% volatility is expected.

Pessimistic forecast: 157.25

Optimistic: 171.77


Biohaven Pharmaceutical Holding stock forecast for Dec 2022.
Estimated Average Forecasted Biohaven Pharmaceutical Holding Price: 160.48. Negative monthly dynamics of the instrument is expected with 12.550% volatility is expected.

Pessimistic forecast: 150.06

Optimistic: 171.60



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 100.68 (23.09.2022) -0.39 %
AbbVie Inc.
ABBV 143.06 (23.09.2022) 0.03 %
Aeterna Zentaris Inc.
AEZS 3.98 (23.09.2022) -3.40 %
Allakos Inc.
ALLK 5.25 (23.09.2022) -0.94 %
Allogene Therapeutics, Inc.
ALLO 10.62 (23.09.2022) -2.03 %
Amgen Inc.
AMGN 226.97 (23.09.2022) -0.34 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 3.31 (23.09.2022) -2.93 %
Aurora Cannabis Inc.
ACB 1.2 (23.09.2022) -1.64 %
Becton Dickinson and Company
BDX 233.92 (23.09.2022) -1.38 %
Biogen Inc.
BIIB 197.78 (23.09.2022) -1.42 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 151.15 (21.09.2022) -0.07 %
BioNTech SE
BNTX 128.35 (23.09.2022) -1.27 %
bluebird bio, Inc.
BLUE 5.62 (23.09.2022) -5.86 %
Boston Scientific Corp.
BSX 39.3 (22.09.2022) -1.16 %
Bristol-Myers Squibb Company
BMY 70.71 (23.09.2022) -0.81 %
Canopy Growth Corp.
CGC 2.84 (23.09.2022) 4.41 %
Castle Biosciences, Inc.
CSTL 24.65 (23.09.2022) -1.40 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 20.86 (23.09.2022) -1.32 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 12.43 (23.09.2022) -2.66 %
Gilead Sciences, Inc.
GILD 62.86 (23.09.2022) -1.43 %
GlaxoSmithKline plc
GSK 29.36 (23.09.2022) -2.17 %
GoodRx Holdings, Inc.
GDRX 5.15 (23.09.2022) -1.90 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 66.89 (23.09.2022) -0.77 %
Inovio Pharmaceuticals, Inc.
INO 1.71 (23.09.2022) -3.39 %
Johnson & Johnson
JNJ 166.72 (23.09.2022) 0.32 %
Medtronic plc.
MDT 82.66 (23.09.2022) -1.08 %
Merck & Co., Inc.
MRK 86.78 (23.09.2022) -0.83 %
Moderna, Inc.
MRNA 123.64 (23.09.2022) -0.55 %
Novartis AG
NVS 76.01 (23.09.2022) -1.46 %
Novavax, Inc.
NVAX 21 (23.09.2022) -6.42 %
ObsEva SA
OBSV 0.141 (23.09.2022) -4.08 %
OrganiGram Holdings Inc.
OGI 0.8914 (23.09.2022) -0.96 %
Pfizer Inc.
PFE 44.08 (23.09.2022) -1.10 %
Regeneron Pharmaceuticals, Inc.
REGN 697.33 (23.09.2022) 1.32 %
Sanofi
SNY 38.4 (23.09.2022) -1.87 %
Schrodinger, Inc.
SDGR 24.12 (23.09.2022) -3.44 %
Senseonics Holdings, Inc.
SENS 1.32 (23.09.2022) 3.13 %
Sorrento Therapeutics, Inc.
SRNE 1.55 (23.09.2022) -4.32 %
Stryker Corp.
SYK 206.93 (23.09.2022) -0.93 %
Sundial Growers Inc.
SNDL 2.3 (23.09.2022) -0.86 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.9 (23.09.2022) -1.99 %
Thermo Fisher Scientific Inc.
TMO 520.79 (23.09.2022) 0.10 %
Tilray, Inc.
TLRY 2.72 (23.09.2022) -2.86 %
UnitedHealth Group, Inc.
UNH 513.61 (23.09.2022) -0.74 %
Veeva Systems Inc.
VEEV 162.57 (23.09.2022) -0.19 %
Zomedica Corp.
ZOM 0.2091 (23.09.2022) -2.74 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.87 (23.09.2022) -6.60 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.